Delivery Order SPE2DB20D1100-SPE2DB24FC0D8

Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,377,182 units of the prescription drug LANTUS SOLOSTAR 100 UNIT/ML 3ML. The $1,187.60 firm fixed price delivery order was awarded on April 23, 2024 by the Medical Supply Chain division of the Defense Logistics Agency (DLA). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the U.S. government. The contract has a ceiling value of $2,649.62 and an ultimate completion date of April 19, 2024. The contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
This federal contract award between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract, valued at $1,187.60, has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The contract has a potential value of $1,187.60 and a completion date of March 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a ceiling value of $2,375.20 and was awarded on May 10, 2024, with a completion date of May 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense (DoD)....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565122508 LANTUS SOLOSTAR 100 UNIT/ML 3ML prescription medication. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price ceiling value of $3,659.14 and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $1,187.60 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply pharmaceuticals and medical supplies to support the Department of Defense's...
This federal contract award, valued at $2,708.11, was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, with a completion date of May 28, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued up...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, with a potential value of $5,605.20. The delivery order has a completion date of February 23, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.08 delivery order contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC0D8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract, valued at $1,198.81, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of May 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/29/24, 9:04 AM